• LAST PRICE
    1.4100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.3600/ 14
  • Ask / Lots
    1.4600/ 1
  • Open / Previous Close
    1.4600 / 1.4100
  • Day Range
    Low 1.3800
    High 1.4600
  • 52 Week Range
    Low 1.3200
    High 22.0550
  • Volume
    169,265
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.46
TimeVolumeBTAI
09:32 ET15501.45
09:41 ET5811.435
09:50 ET10001.435
09:52 ET19001.43
09:54 ET61001.435
09:59 ET1001.435
10:03 ET19591.4396
10:08 ET79761.4301
10:10 ET1001.435
10:14 ET1401.435
10:28 ET2501.43
10:30 ET6971.4301
10:32 ET6351.435
10:33 ET62901.43
10:35 ET3061.4238
10:37 ET1001.43
10:39 ET12001.425
10:42 ET1001.425
10:46 ET1001.425
10:48 ET1001.425
10:51 ET27531.435
10:57 ET1001.435
11:00 ET1001.435
11:09 ET2001.4399
11:15 ET1001.43
11:36 ET1001.43
11:38 ET1001.435
11:40 ET1001.44
11:47 ET3001.4301
11:54 ET1671.4303
11:56 ET8001.43
12:00 ET1001.42
12:03 ET62451.415
12:07 ET20001.42
12:12 ET5191.418
12:20 ET5801.41
12:21 ET11001.41
12:23 ET1501.41
12:30 ET3001.41
12:32 ET27071.4001
12:34 ET7871.4032
12:39 ET1001.405
12:43 ET1001.405
12:48 ET109851.4001
12:52 ET1001.4099
12:54 ET1001.4098
12:57 ET1001.405
01:03 ET3301.405
01:08 ET10001.4
01:12 ET34441.41
01:17 ET2001.405
01:19 ET1001.405
01:21 ET1001.405
01:30 ET27561.4
01:33 ET1001.4
01:35 ET3001.4
01:37 ET1001.4
01:39 ET1001.4
01:42 ET7021.405
01:48 ET1001.4
01:51 ET32301.405
01:55 ET1001.405
01:57 ET1001.41
02:02 ET7001.405
02:04 ET2001.405
02:06 ET18001.4001
02:08 ET34501.4087
02:11 ET1001.405
02:13 ET2001.405
02:18 ET1001.4
02:29 ET13001.408
02:31 ET1001.4
02:33 ET1001.405
02:38 ET2001.4
02:40 ET4001.4
02:47 ET2001.4
02:51 ET2001.405
02:56 ET2001.405
02:58 ET14661.4
03:02 ET1001.4
03:03 ET3001.4099
03:05 ET3001.4
03:07 ET5001.41
03:12 ET7001.4084
03:16 ET2001.41
03:21 ET2001.4
03:23 ET1001.405
03:25 ET154421.395
03:34 ET45721.39
03:36 ET11801.39
03:38 ET5001.3821
03:39 ET1001.38
03:41 ET2291.38
03:43 ET1241.38
03:45 ET9491.38
03:48 ET5331.38
03:50 ET9001.38
03:52 ET10351.38
03:54 ET48381.3899
03:56 ET27801.395
03:57 ET14001.395
03:59 ET37311.41
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBTAI
BioXcel Therapeutics Inc
53.7M
-0.3x
---
United StatesCLNN
Clene Inc.
53.2M
-0.8x
---
United StatesIMMX
Immix Biopharma Inc
53.9M
-2.2x
---
United StatesVTVT
vTv Therapeutics Inc
54.7M
-2.6x
---
United StatesANEB
Anebulo Pharmaceuticals Inc
52.4M
-5.8x
---
United StatesOCEA
Ocean Biomedical Inc
55.4M
-1.1x
---
As of 2024-06-14

Company Information

BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop medicines in neuroscience. Its subsidiary, OnkosXcel Therapeutics, develops medicines in immuno-oncology. The Company’s most advanced neuroscience candidate, BXCL501, is an investigational, proprietary, orally dissolving film formulation of Dex in development for the treatment of agitation associated with psychiatric and neurological disorders. It is continuing to develop BXCL501 for the potential acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home setting and for the potential acute treatment of agitation (non-daily) associated with dementia due to probable Alzheimers disease in the at-home setting and in care facilities. Its most advanced immuno-oncology candidate, BXCL701, is an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors.

Contact Information

Headquarters
555 Long Wharf DrNEW HAVEN, CT, United States 06511-6107
Phone
203-643-8060
Fax
302-636-5454

Executives

Lead Independent Chairman of the Board
Peter Mueller
President, Chief Executive Officer, Director
Vimal Mehta
Chief Financial Officer, Senior Vice President
Richard Steinhart
Executive Vice President, Chief Scientific Officer
Frank Yocca
Executive Vice President, Chief of Product Development and Medical Officer
Vincent O'Neill

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$54.8M
Revenue (TTM)
$1.8M
Shares Outstanding
37.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.34
EPS
$-5.18
Book Value
$-1.89
P/E Ratio
-0.3x
Price/Sales (TTM)
31.2
Price/Cash Flow (TTM)
---
Operating Margin
-8,243.11%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.